PBM Pharmaceuticals, Inc. News

Scientists Reveal Roadmap to Brain Health That Can Be Passed Down to Future Generations: Exercise, Omega-3, Folic Acid, Vitamin B6, and Vitamin B12

GORDONSVILLE, Va., July 28 PRNewswire — New findings from a comprehensive analysis of more than 160 clinical studies have revealed the importance of routine exercise and a balanced diet on brain health that can be passed down through future generations. According to a recent press release*, Fernando Gomez-Pinilla, a UCLA professor of neurosurgery and physiological science, identified key nutrients that are beneficial in warding off mental disorders, including omega-3 (particularly DHA), folic acid, vitamin B6, and vitamin B12.

"Dietary deficiency of omega-3 fatty acids in humans has been associated with increased risk of several mental disorders, including attention-deficit disorder, dyslexia, dementia, depression, bipolar disorder and schizophrenia," said Gomez-Pinilla. "Omega-3 fatty acids are essential for normal brain function."

Barbara S. Levine, R.D., Ph.D., director of the first NIH-funded Nutrition Information Center at Weill Cornell Medical College, believes the analysis provides a roadmap to supporting brain health.

"These scientists also covered the beneficial effects of folic acid and other B vitamins, especially when it comes to preventing cognitive decline and dementia among the elderly," said Dr. Levine. "This comprehensive analysis points to the importance of dietary nutrients, which oftentimes are not plentiful in the food we eat."

Dr. Levine is a scientific advisory board member of www.dhaandbvitamins.org, an educational Web site developed by specialists at Weill Cornell Medical College and other major academic medical centers. She has been recommending the prescription-only product Animi-3(R) to patients who have diseases associated with deficiencies in DHA, folic acid, and B vitamins.

"Physicians are using Animi-3 to deliver the highly refined omega-3, DHA, folic acid, and vitamins B6 and B12 to different types of patients," said PBM Pharmaceuticals President Jack Schramm, who developed the Animi-3 formula. "Of particular interest here is the effect addressing deficiencies in DHA may have on brain health as well as the brains of future generations."

Each capsule of Animi-3 contains 500 mg of omega-3, (350 mg of DHA), 1 mg of folic acid, 12.5 mg of B6, and 12 mcg of B12. For more information, visit www.animi-3.com.

* Retrieved July 21, 2008, from www.newsroom.ucla.edu/portal/ucla/scientists-learn-how-food-affects-52668.aspx

Animi-3 is not intended to diagnose, treat, or cure any disease. Contact: Joe Shields Director of Public Relations (800) 959-2066 ext. 131 jshields@pbmproducts.com

SOURCE PBM Pharmaceuticals, Inc.

Send this news item to a friend.

Print This Page